ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. Total liabilities

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.5B
P/E ratio
-45.3x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 2025688-24.27%
Mar 31, 2024908-3.99%
Mar 31, 2023946+1.55%
Mar 31, 2022932-2.42%
Mar 31, 2021955+16.36%
Mar 31, 2020821-1.60%
Mar 31, 2019834+8.06%
Mar 31, 2018772+42.57%
Mar 31, 2017541-6.43%
Mar 31, 2016578+26.83%
Mar 31, 2015456

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat